semaglutide lawsuit 2025 Ozempic UPDATE (February 2025) Novo Nordisk A/S (NVO) Securities
Description
No randomized controlled trials have shown superior outcomes with combination treatment, and expert consensus emphasizes that adequate dosing of one agent should be attempted before considering any off-label approach
FAQs What prompted concerns about GLP-1 drugs and thyroid cancer
Reductions in BMI and waist circumference were also observed
Food and Drug Administration to treat Type 2 diabetes, but some doctors prescribe the medication "off-label" for weight loss, as is permissible by the U.S
